Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kevin Qiu
Institutions:
University of Virginia Medical Center,
University of Virginia Cancer Center,
University of Virginia
Observed institutions:
Northwestern University,
University of Virginia Medical Center,
University of Virginia Cancer Center,
University of Virginia
ORCID:
0009-0008-0168-7306
Observed ORCID:
0009-0008-0168-7306
OpenAlex ID:
A5017862525
Inhibitory co-receptor Lag3 supports Foxp3+ regulatory T cell function by restraining Myc-dependent metabolic programming
2024
·
Dongkyun Kim
, Giha Kim
, et al.
·
Immunity
·
56
Single-Cell Analysis Uncovers Striking Cellular Heterogeneity of Lung-Infiltrating Regulatory T Cells during Eosinophilic versus Neutrophilic Allergic Airway Inflammation
2024
·
Supinya Iamsawat
, Rongzhen Yu
, et al.
·
The Journal of Immunology
·
8
PDF
Chromatin structure and 3D architecture define the differential functions of PU.1 regulatory elements in blood cell lineages
2024
·
Kevin Qiu
, Duc C. Vu
, et al.
·
Epigenetics & Chromatin
·
7
PDF
The C/EBPα-(PU.1- LOUP ) regulatory circuit regulates monocyte/macrophage development and immune functions
2026
·
A. S. M. Waliullah
, Thuy-An Nguyen
, et al.
·
Blood
·
3
Targeting persister cells: proactively overcoming therapy resistance in aggressive B cell lymphomas
2026
·
Jianguo Tao
, Kevin Qiu
, et al.
·
Trends in cancer
·
3
Addiction of primary cutaneous γδ T cell lymphomas to JAK/STAT signaling
2025
·
Yue Zhang
, Julia A. Yescas
, et al.
·
Journal of Clinical Investigation
·
3
PDF
Transcriptional Condensates: Epigenetic Reprogramming and Therapeutic Targets in Hematologic Malignancies
2025
·
Kevin Qiu
, Qing Yin
, et al.
·
Cancers
·
2
PDF
Modeling Alzheimer’s Disease with APOE4 Neuron-Glial Brain Assembloids Reveals IGFBPs as Therapeutic Targets
2025
·
Eliana Sherman
, Kevin Qiu
, et al.
·
SSRN Electronic Journal
·
2
Synthetic lethality of MCL-1 inhibition and CAR-T therapy in aggressive B-cell lymphoma
2026
·
Jing Gao
, Xiaohong Zhao
, et al.
·
Leukemia
·
1
PDF
Therapeutic resistance in aggressive B-cell lymphoma is overcome through the reciprocal enhanced efficacy by CDK9 inhibitors and CAR-T cells
2025
·
Allen Hu
, Qing Yin
, et al.
·
Blood
·
1
PDF
Hematopoietic Transcription Factor PU.1 and Enhancer RNA Loup Establish a Feedforward Regulatory Loop Governing Monocyte/Macrophage Biology
2024
·
A S M Waliullah
, Kevin Qiu
, et al.
·
Blood
·
1
Combating CD24 to overcome CD19 CAR-T resistance via induction of innate and adaptive immunity in B-cell malignancies
2026
·
Qing Yin
, Jing Gao
, et al.
·
Leukemia
PDF
Synergistic vulnerability of aggressive B-cell lymphoma to combined MCL-1 inhibition and CAR-T cell therapy
2025
·
Jing Gao
, Xiaohong Zhao
, et al.
·
Blood
PDF
Abstract 5364: Multi-omic analyses reveal epigenetic and transcriptomic reprogramming behind ibrutinib-venetoclax resistance development in mantle cell lymphoma
2025
·
Kevin Qiu
, Jing Gao
, et al.
·
Cancer Research
Abstract 1187: An integrated DNA interactome and transcriptome profiling reveals a PU.1/enhancer RNA-mediated feedforward regulatory loop regulating myeloid cell function and leukemia relapse
2025
·
Asm Waliullah
, Kevin Qiu
, et al.
·
Cancer Research
An integrated DNA interactome and transcriptome profiling reveals a PU.1/enhancer RNA-mediated Feed-forward Regulatory Loop Regulating monocyte/macrophage development and innate immune functions
2025
·
A S M Waliullah
, Kevin Qiu
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
Dysregulation of Transcription Machinery Drives the Acquisition of BTK Inhibitor and Venetoclax Treatment Resistance in Mantle Cell Lymphoma
2024
·
Jing Gao
, Kevin Qiu
, et al.
·
Blood
Show more works
View as search
Works count:
17
Citation count:
87
H-index:
3
I10-index:
1
Year
Topic
Type